Symbols

CG

The Carlyle Group·NASDAQ

--(--)

CG fundamentals

CG Q4 2025 Earnings

The Carlyle Group (CG) released its earnings on Feb 6, 2026: revenue was 1.09B (YoY +15.11%), beat estimates; EPS was 1.01 (YoY +9.78%), beat estimates.

Revenue / YoY

1.09B

+15.11%

EPS / YoY

1.01

+9.78%

Report date

Feb 6, 2026

CG Earnings Call Summary for Q4,2025

Record Financial Results: 2025 saw 12% FRE growth to $1.24B, 47% margin, and $54B inflows, driven by Carlyle AlpInvest and Global Credit leadership.
IPO Dominance: $10B in IPOs over 2 years, including Medline ($7B), largest sponsor-backed IPO globally.
Portfolio Resilience: GP funds appreciated 17%-60%, with $18B capital returned to investors.
Strategic Expansion: Global Wealth AUM doubled YoY, and Global Credit DE rose 21% YoY to $402M.
Balance Sheet Strength: $1.7B DE, $2B cash, and $3B net accrued carry support 2026 growth initiatives.

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

The Carlyle Group (CG) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

The Carlyle Group (CG)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

The Carlyle Group (CG)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

The Carlyle Group (CG)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown